Publicité
Publicité
INM
InMed Pharmaceuticals Inc. Common Shares
1.30
USDSponsorisé
+0.05
+4.16%
09 janv., 15:59 UTC -5
Fermé
Après-marché
1.30
0.00
+0.23%
INM Rapports sur les bénéfices
Ratio de surprise positive
INM a dépassé 2 des 7 dernières estimations.
29%
Prochain rapport
Date du prochain rapport
10 févr. 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/--
Variation implicite de Q1 26 (Revenue/ EPS)
--
/--
Variation implicite de Q2 25 (Revenue/ EPS)
--
/--
InMed Pharmaceuticals Inc. Common Shares earnings per share and revenue
On 06 nov. 2025, INM reported earnings of -- USD per share (EPS) for Q1 26, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q2 26, -- analystes forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
What were InMed Pharmaceuticals Inc. Common Shares's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, InMed Pharmaceuticals Inc. Common Shares reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to InMed Pharmaceuticals Inc. Common Shares's Q1 2026 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is InMed Pharmaceuticals Inc. Common Shares expected to report next?
The next earning report is scheduled for 10 févr. 2026.
What are the forecasts for InMed Pharmaceuticals Inc. Common Shares's next earnings report?
Based on --
analystes, InMed Pharmaceuticals Inc. Common Shares is expected to report EPS of -- and revenue of -- for Q2 2026.
Which companies are reporting earnings today?
Chèque FXEmpire's Earnings Calendar for today's list of reporting companies.
Publicité